PYNG Technologies Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Gold/Mining/Energy : PYNG Technologies

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: HotShot1 who wrote (4146)	7/12/1999 11:56:00 PM
From: Jack Rayfield	Read Replies (2) of 8117

For those still interested Site to view Pyng Profile at Discovery 99 New York City: w3otc.com Highlights: ( Excerpts) Net revenue per annum within the first five years in projected at greater than USD $35 million. The product is disposable guaranteeing an ongoing revenue stream. There are also significant derivative product opportunities, for example, pediatric intraosseous infusion, bone marrow aspiration system. Financial Data: The Corporation has not attempted, during the field trial work, to generate sales. Pyng Medical Corp. is currently gearing up for mass production and sales in latter 1999. The Corporation has reasonable funds on hand to enter into this phase. Expanding market opportunities will require more capital.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next